Overall survival and disease-free survival by WBC count
| . | WBC . | M3 . | M3V . | P . | ||||
|---|---|---|---|---|---|---|---|---|
| n . | 5-year, % (SE) . | 10-year, % (SE) . | n . | 5-year, % (SE) . | 10-year, % (SE) . | |||
| OS | .87* | |||||||
| 0-< 5 | 566 | 84 (1.6) | 81 (1.7) | 35 | 80 (6.8) | 80 (6.8) | .7 | |
| ≤ 5-< 10 | 61 | 70 (5.8) | 70 (5.8) | 26 | 84 (7.2) | 84 (7.2) | .15 | |
| ≥ 10 | 121 | 68 (4.2) | 66 (4.4) | 94 | 62 (5.0) | 62 (5.0) | .47 | |
| DFS | .5* | |||||||
| 0-< 5 | 521 | 85 (1.6) | 82 (1.8) | 31 | 84 (6.6) | 84 (6.6) | .87 | |
| ≤ 5-< 10 | 49 | 80 (5.8) | 80 (5.8) | 24 | 79 (8.3) | 79 (8.3) | .96 | |
| ≥ 10 | 99 | 63 (4.9) | 62 (5.0) | 72 | 67 (5.6) | 67 (5.6) | .45 | |
| . | WBC . | M3 . | M3V . | P . | ||||
|---|---|---|---|---|---|---|---|---|
| n . | 5-year, % (SE) . | 10-year, % (SE) . | n . | 5-year, % (SE) . | 10-year, % (SE) . | |||
| OS | .87* | |||||||
| 0-< 5 | 566 | 84 (1.6) | 81 (1.7) | 35 | 80 (6.8) | 80 (6.8) | .7 | |
| ≤ 5-< 10 | 61 | 70 (5.8) | 70 (5.8) | 26 | 84 (7.2) | 84 (7.2) | .15 | |
| ≥ 10 | 121 | 68 (4.2) | 66 (4.4) | 94 | 62 (5.0) | 62 (5.0) | .47 | |
| DFS | .5* | |||||||
| 0-< 5 | 521 | 85 (1.6) | 82 (1.8) | 31 | 84 (6.6) | 84 (6.6) | .87 | |
| ≤ 5-< 10 | 49 | 80 (5.8) | 80 (5.8) | 24 | 79 (8.3) | 79 (8.3) | .96 | |
| ≥ 10 | 99 | 63 (4.9) | 62 (5.0) | 72 | 67 (5.6) | 67 (5.6) | .45 | |
Comparing overall M3 versus M3V, adjusted for by WBC category.